Inhibikase Therapeutics Inc Ordinary Shares (NASDAQ:IKT)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IKT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IKT

  • Market Cap$69.050m
  • SymbolNASDAQ:IKT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS45719W1062

Company Profile

Inhibikase Therapeutics Inc is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Diseases and related disorders inside and outside the brain. Its pipeline product, IkT-148009, targets underlying disease mechanisms to reverse the course of Parkinson's disease and the GI complications of Parkinson's disease.

Latest IKT news

Currently there for this company. Visit our news hub for other news .